The number needed to treat adjusted for explanatory variables in regression and survival analysis: Theory and application

Type: Article

Publication Date: 2022-04-26

Citations: 3

DOI: https://doi.org/10.1002/sim.9418

View Chat PDF

Abstract

The number needed to treat (NNT) is an efficacy index commonly used in randomized clinical trials. The NNT is the average number of treated patients for each undesirable patient outcome, for example, death, prevented by the treatment. We introduce a systematic theoretically-based framework to model and estimate the conditional and the harmonic mean NNT in the presence of explanatory variables, in various models with dichotomous and nondichotomous outcomes. The conditional NNT is illustrated in a series of four primary examples; logistic regression, linear regression, Kaplan-Meier estimation, and Cox regression models. Also, we establish and prove mathematically the exact relationship between the conditional and the harmonic mean NNT in the presence of explanatory variables. We introduce four different methods to calculate asymptotically-correct confidence intervals for both indices. Finally, we implemented a simulation study to provide numerical demonstrations of the aforementioned theoretical results and the four examples. Numerical analysis showed that the parametric estimators of the NNT with nonparametric bootstrap-based confidence intervals outperformed other examined combinations in most settings. An R package and a web application have been developed and made available online to calculate the conditional and the harmonic mean NNTs with their corresponding confidence intervals.

Locations

Similar Works

Action Title Year Authors
+ PDF Chat Estimate risk difference and number needed to treat in survival analysis 2018 Zhongheng Zhang
Federico Ambrogi
Alex Bokov
Hongqiu Gu
Edwin de Beurs
Khaled Ahmed Eskaf
+ Hazard Ratio 2014 Claudia Schmoor
Erika Graf
+ Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation 2024 Jiawei Wei
Jiajun Xu
Björn Bornkamp
Ray Lin
Hong Tian
Dong Xi
Xin Zhang
Ziqiang Zhao
Satrajit Roychoudhury
+ Improving testing and description of treatment effect in clinical trials with survival outcomes 2018 Song Yang
+ Baseline-Covariate Adjusted Confidence Interval for Proportional Difference Between Two Treatment Groups in Clinical Trials 2019 Jingjing Chen
Fang Liu
+ PDF Chat The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials 2016 Julien Péron
Pascal Roy
Brice Ozenne
Laurent Roche
Marc Buyse
+ PDF Chat Reduction in number to treat versus number needed to treat 2021 Chenyang Zhang
Guosheng Yin
+ Baseline-covariate adjusted confidence interval for proportional difference between two treatment groups in clinical trials 2019 Jingjing Chen
Fang Liu
+ Conditional and Unconditional treatment effects in randomized clinical trials: Estimands, Estimation, and Interpretation 2023 Jiawei Wei
Jiajun Xu
Björn Bornkamp
Ray Lin
Hong Tian
Dong Xi
Xin Zhang
Ziqiang Zhao
Satrajit Roychoudhury
+ Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation 2023 Jiawei Wei
Jiajun Xu
Björn Bornkamp
Ray Lin
Hong Tian
Dong Xi
Xin Zhang
Ziqiang Zhao
Satrajit Roychoudhury
+ Benefit–Risk Assessment Using Number Needed to Treat and Number Needed to Harm for Time-to-Event Endpoints 2016 Chunlei Ke
Qi Jiang
+ Estimands, Estimators and Sensitivity Analysis in Clinical Trials 2019 Craig Mallinckrodt
Geert Molenberghs
Ilya Lipkovich
Bohdana Ratitch
+ PDF Chat How big is a big hazard ratio in clinical trials? 2023 Yuanyuan Lu
Wei Wang
Yangxin Huang
Henian Chen
+ Optimal confidence intervals for the relative risk and odds ratio 2022 Weizhen Wang
Shuiyun Lu
Tianfa Xie
+ Analyzing time to event outcomes with a Cox regression model 2012 Stephen J. Walters
+ Composite endpoints in clinical trials : computational tools, practical guidelines and methodological extensions 2016 Moisés Gómez Mateu
+ PDF Chat Statistical considerations for evaluating treatment effect under various non-proportional hazard scenarios 2025 Xinyu Zhang
Erich J. Greene
Ondřej Bláha
Wei Wei
+ Statistical methods for composite endpoints 2021 Hironori Hara
David van Klaveren
Norihiro Kogame
Ply Chichareon
Rodrigo Modolo
Mariusz Tomaniak
Masafumi Ono
Hideyuki Kawashima
Kuniaki Takahashi
Davide Capodanno
+ PDF Chat Sample size for a noninferiority clinical trial with time-to-event data in the presence of competing risks 2017 Dong Han
Zheng Chen
Yawen Hou
+ PDF Chat Improved Confidence Intervals for Fixed Term Survival Probabilities in a Small Two-Arm Trial 2020 Chen Qian
Jianmin Pan
Craig J. McClain
Shesh Rai

Citing (30)

Action Title Year Authors
+ Asymptotic Statistics 1998 Aad van der Vaart
+ The<i>R</i>Package<b>survsim</b>for the Simulation of Simple and Complex Survival Data 2014 David Moriña
Albert Navarro
+ A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model 2013 Ruediger P. Laubender
Ralf Bender
+ Statistics and Causal Inference 1986 Paul W. Holland
+ Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model 2009 Peter C. Austin
+ On Confidence Bounds for the Ratio of Net Differences in the “Gold Standard” Design with Reference, Experimental, and Placebo Treatment 2005 Joachim Röhmel
+ Cox's Regression Model for Counting Processes: A Large Sample Study 1982 P. Andersen
Richard D. Gill
+ Number Needed to Treat: Properties and Problems 2000 Jane L. Hutton
+ PDF Chat Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model 2010 Rüdiger P. Laubender
Ralf Bender
+ The number needed to treat: a useful clinical measure or a case of the Emperor's new clothes? 2003 Andrew P. Grieve
+ Number needed to treat (NNT): estimation of a measure of clinical benefit 2001 Stephen D. Walter
+ Estimating adjusted NNTs in randomised controlled trials with binary outcomes: A simulation study 2010 Ralf Bender
Volker Vervölgyi
+ Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes 2009 Peter C. Austin
+ A Comparison of Certain Bootstrap Confidence Intervals in the Cox Model 1994 Deborah Burr
+ Calculating the “number needed to be exposed” with adjustment for confounding variables in epidemiological studies 2002 Ralf Bender
Maria Blettner
+ Bias of estimates of the number needed to treat 2005 Bradford W Duncan
Ingram Olkin
+ On the clinical meaningfulness of a treatment's effect on a time‐to‐event variable 2011 Steven Snapinn
Qi Jiang
+ Estimating adjusted NNT measures in logistic regression analysis 2007 Ralf Bender
Oliver Kuß
Mandy Hildebrandt
Ulrich Gehrmann
+ PDF Chat A Large Sample Study of Cox's Regression Model 1981 Anastasios A. Tsiatis
+ Consequences of dichotomization 2008 Valerii V. Fedorov
Frank Mannino
Rongmei Zhang
+ PDF Chat The Number Needed to Treat: 25 Years of Trials and Tribulations in Clinical Research 2015 Samy Suissa
+ PDF Chat Number needed to treat (NNT) in clinical literature: an appraisal 2017 Diogo Mendes
Carlos Alves
Francisco Batel Marques
+ PDF Chat Statistical pitfalls of personalized medicine 2018 Stephen Senn
+ PDF Chat An alternative approach for estimating the number needed to treat for survival endpoints 2019 Zhao Yang
Guosheng Yin
+ Systematic analysis of the number needed to treat 2020 Valentin Vancak
Yair Goldberg
Stephen Z. Levine
+ PDF Chat The number needed to treat adjusted for explanatory variables in regression and survival analysis: Theory and application 2022 Valentin Vancak
Yair Goldberg
Stephen Z. Levine
+ PDF Chat Bootstrap Methods: Another Look at the Jackknife 1992 Bradley Efron
+ Disappointing dichotomies 2003 Stephen Senn
+ Analysis of Survival Data 2018 D.R. Cox
D. Oakes
+ Nonparametric Estimation from Incomplete Observations 1958 Edward L. Kaplan
Paul Meier